Ophthalmology
Strabismus
33
Pipeline Programs↗
6
Active Trials↗
10
Companies Involved↗
Strabismus is a moderately active landscape with 33 programs across 10 companies. The most active players are Vitae Pharmaceuticals Inc., an Allergan affiliate, GSK, Avyxa. 8 therapies are approved with 3 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical21
Phase 1
No programs
Phase 33
Analysis
Trial Status
37
clinical trials
Completed24 · 65%
Unknown status7 · 19%
Not yet recruiting5 · 14%
Recruiting1 · 3%
Clinical Trials
Trial Activity
37 trials
Low Flow Anesthesia in Children Undergoing Strabismus Surgery
Not yet recruiting·—·Phase 4·NCT06560268·150 enrolled
Pain After Strabismus Surgery
Not yet recruiting·—·Phase 2·NCT06689943·80 enrolled
Effect of Dexmedetomedine in Subtenon's Block on Emergence Agitation in Pediatric Strabismus Surgery
Completed·—·N/A·NCT04485273·100 enrolled
Exercise Interventions for Improving Eye Control Post Strabismus Surgery
Completed·—·N/A·NCT05303779·40 enrolled
Propofol Versus Sevoflurane Anesthesia in Pediatric Strabismus Surgery: Feasibility of BIS Monitoring
Completed·—·N/A·NCT04485117·100 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)